You just read:

Camurus Announces That FDA Grants Priority Review of NDA for Weekly and Monthly CAM2038 Buprenorphine Depots for Treatment of Opioid Use Disorder

News provided by

Camurus AB

Sep 18, 2017, 04:17 ET